Every SEC Form 3/4/5 on record for this filer (CIK 1652410) — 4 issuers, 47 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | See Remarks | 2019-01-09 → 2026-06-02 | 30 | −$1M |
| ITRM | Iterum Therapeutics plc | Director · lapsed | 2021-03-19 → 2023-06-15 | 7 | — |
| AYTU | AYTU BIOPHARMA, INC | Director · lapsed | 2021-03-26 → 2021-04-12 | 2 | — |
| NEOS | Neos Therapeutics, Inc. | Director · lapsed | 2015-09-03 → 2021-03-19 | 8 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| XERS | 2026-06-01 | Sell | 16,667 | $6.06 | $101,002 | 1,176,506 |
| XERS | 2026-05-01 | Sell | 16,667 | $6.23 | $103,835 | 1,193,173 |
| XERS | 2026-04-01 | Sell | 16,667 | $5.99 | $99,835 | 1,209,840 |
| XERS | 2026-03-02 | Sell | 100 | $7.06 | $706 | 1,226,507 |
| XERS | 2026-03-02 | Sell | 16,567 | $6.24 | $103,378 | 1,226,607 |
| XERS | 2026-02-02 | Sell | 16,667 | $7.45 | $124,169 | 1,243,174 |
2 of 4 issuers are covered and open a security page; the rest are on file here only.
